Saturday 17 October 2026
Export XAGE’s income statement to Excel — free account
Longevity Health Holdings, Inc.
XAGE Consumer Defensive Household & Personal Products
Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS grew 51.3% and free cash flow grew 73.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.11
0.00
0.00%
Follow XAGE
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '17 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — |
P/S ratio |
0.22 | 1.58 | — | — | — | — |
Altman Z-Score |
(56.91) | (80.00) | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(141.83) | (197.81) | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — |
P/Operating CF |
(1.40) | (7.72) | — | — | — | — |
Beneish M-Score |
22.85 | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | — | — | — | — |
EV/Sales |
0.64 | 1.93 | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
(0.37) | (1.88) | — | — | — | — |
EV/FCF |
(0.36) | (1.86) | — | — | — | — |
Quick Ratio |
0.09 | 0.08 | 0.08 | 0.02 | 2.35 | — |
Current Ratio |
0.25 | 0.16 | 1.63 | 0.08 | 2.95 | — |
Net Debt/EBITDA |
0.10 | 0.03 | 0.50 | 0.04 | 1.66 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
1.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.48 | 0.38 | 0.52 | 0.36 | 1.37 | — |
Capex/Depreciation |
(0.07) | 0.00 | (0.19) | 0.00 | — | — |
Interest Coverage |
(390.53) | (169.44) | (6.96) | (3.23) | (57.70) | — |
| 130.54% | (103.50%) | 247.23% | 45.16% | 0.00% | — | |
| (359.56%) | (31.70%) | (49.08%) | (12.23%) | (0.42%) | — | |
ROIC |
0.00% | 0.00% | (17.01%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
117.75% | 215.68% | (65.56%) | 149.31% | (51.21%) | — |
Average Days of Receivables |
6.96 | 2,219.75 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
41.24% | 2,096.02% | 0.00% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
383.46% | 7,762.82% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.02 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
36.22% | 1,644.14% | 0.00% | 0.00% | — | — |
Graham Net Nets |
(14.65) | (0.88) | — | — | — | — |
Graham Number |
21.62 | 46.59 | — | — | — | — |
Earnings Yield |
(1,686.67%) | (174.19%) | — | — | — | — |
Free Cash Flow Yield |
(779.59%) | (65.89%) | — | — | — | — |
Revenue per Share |
1.34 | 0.07 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(2.33) | (5.47) | (22.75) | (58.61) | (3.38) | — |
Capex per Share |
(0.01) | 0.00 | (0.08) | (0.12) | 0.00 | — |
Free Cash Flow per Share |
(2.34) | (5.47) | (22.83) | (58.73) | (3.38) | — |
Cash per Share |
0.49 | 0.22 | 7.94 | 2.19 | 5.80 | — |
Shareholders Equity per Share |
(4.10) | (6.62) | 67.44 | (108.97) | (35.70) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(4.10) | (6.62) | 67.44 | (108.97) | (35.70) | — |
Free Cash Flow |
(3.34) | (3.89) | (8.38) | (3.44) | (0.45) | — |
Working Capital |
(5.97) | (4.92) | 24.40 | (6.69) | 0.64 | — |
Capital Expenditures |
(0.01) | — | (0.03) | (0.01) | — | — |
Net Current Asset Value |
(6.28) | (5.23) | 23.70 | (7.52) | (159.21) | — |
EV/EBIT |
0.00 | 0.00 | — | — | — | — |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | — | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — |
| Other line items | ||||||
Depreciation/Fixed assets |
2.12 | 1.90 | 0.83 | 8.97 | — | — |
Cash ROIC |
64.79% | 85.46% | (30.29%) | 55.01% | 11.31% | — |
Accounts Receivable Turnover |
11.17 | 0.20 | — | — | — | — |
Accounts Payable Turnover |
0.19 | 0.00 | 0.00 | — | — | — |
Inventory Turnover |
1.53 | 0.00 | — | — | — | — |
Average Days of Payables |
2,005.43 | 231,438.52 | 0.00 | 0.00 | — | — |
Days of Inventory on Hand |
429.65 | 6,199.30 | — | — | — | — |
Average Receivables |
0.17 | 0.26 | — | — | — | — |
Average Payables |
4.28 | 4.24 | 3.28 | — | — | — |
Average Inventory |
0.54 | — | — | — | — | — |
Average Assets |
1.92 | 32.71 | 32.85 | 78.59 | 77.71 | — |
Average Common Equity |
(5.29) | 10.02 | (6.52) | (21.28) | — | — |
Columns are period end dates